What our clients say
Our close cooperation and relationship with our clients is a great advantage when resolving cases . We have many good things to say about our client relations , but what do our clients say about us ? Many of them have commented on our work for them .
Breye Therapeutics Breye Therapeutics , a biotech company headquartered in Denmark , raised seed capital of EUR 4 million from Novo Holdings and Sound Bioventures .
Partner : Christina Bruun Geertsen
" Our collaboration with Kromann Reumert on the seed investment was characterised by a high degree of professionalism and experience . Kromann Reumert ’ s experience-based advice helped build trust and allowed us to focus on the essentials of the contract documents .”
Ulrik Mouritzen , CEO , Breye Therapeutics
DBC Invest A / S DBC Invest made its fifth investment , a double-digit million investment in BB Biogas .
Partner : Maria Holst Levin
" We choose our lawyer based on trust and a balancing of the price and quality of the advice we receive . Speed and prioritisation are important parameters to us , and they are always delivered . We use Kromann Reumert because they have advised on many national and international biogas projects , and we benefit from that experience ."
Rune Ledgaard Sørensen , CEO of DBC & board member of Vrejlev Bioenergi , Sindal Biogas and Vestjysk Biogas
FLSmidth FLSmidth made a demand under a guarantee in a case that started back in 2008 following a default by the borrower . The Maritime and Commercial High Court found the guarantee call justified and dismissed the claim for DKK 347 million .
Partner : Jakob Dahl Mikkelsen
" This highly complex case dates back many years . Many of the people involved were no longer employed in FLSmidth , which made it absolutely necessary to have a competent lawyer in charge . There was a vast amount of historical documents , and the writ was long . It was not a walk in the park to solve this dispute ."
Jakob Grünfeld , General Counsel EMEAI at FLSmidth
20